ACM
CLVS

AlphaCrest Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

AlphaCrest Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70,236
Closed -$1.04M – 1366
2019
Q2 		$1.04M Buy
+70,236
New +$1.27M 0.09% 374

Other funds holding CLVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

AlphaCrest Capital Management's CLVS Position: Q3 2019 in Review

AlphaCrest Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2019, closing a stake of 70,236 shares — an estimated $1.04M sold.

AlphaCrest Capital Management first reported a position in CLVS in Q2 2019 and held it in 1 quarter. The position peaked at $1.04M in Q2 2019. 153 funds tracked by Wall St. Rank hold CLVS as of Q3 2019.

  • AlphaCrest Capital Management reported no remaining Clovis Oncology, Inc. position as of Q3 2019 after selling out during the quarter.
  • AlphaCrest Capital Management sold 70,236 Clovis Oncology, Inc. shares in Q3 2019, an estimated $1.04M.
  • AlphaCrest Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2019 and held it in 1 quarter.
  • AlphaCrest Capital Management's Clovis Oncology, Inc. position peaked at $1.04M in Q2 2019.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2019.

Based on AlphaCrest Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.